Drug Logix India is a chemical research-based pharmaceutical company established in India with the mission of providing cost-effective and time-bound high-quality key starting materials (KSMs), intermediates of Active Pharmaceutical Ingredients (APIs) and impurity synthesis services to the global pharmaceutical industry.
We are involved in the research, development and manufacturing of quality key starting materials (KSMs), intermediates of Active Pharmaceutical Ingredients (APIs) and supply of synthesized impurity standards. Our goal is to know the exact needs of our customers and provide our products and services to their complete satisfaction.
Get in Touch
Dr. Surya Raguthu, MD, is a highly accomplished, multi-board-certified physiatrist and pain management specialist with over 30 years of clinical experience. Based in Texas, he serves as the Medical Director of ACE Pain Management & Physical Therapy (with prominent multidisciplinary facilities in Sugar Land and Brownsville, Texas) and has a legacy of leadership in clinical rehabilitation, healthcare operations, and pharmaceutical-adjacent ventures.
Dr. Surya Raguthu brings a unique blend of strategic capital and a lifelong passion for pharmaceutical innovation to Drug Logix India. Rather than viewing pharmaceuticals through a purely financial lens, he is motivated by the tangible impact of translating complex laboratory chemistry into scalable, global therapeutic solutions. At Drug Logix India, Dr. Raguthu serves as a strategic catalyst — bridging the gap between visionary science and robust corporate execution.
The founder of Drug Logix India brings 21 years of rich experience to the pharmaceutical industry, offering deep expertise in API process development, commercial manufacturing, and the pharmaceutical generic domain. His comprehensive technical knowledge spans R&D, technology transfer, quality systems, intellectual property rights (IPR), and regulatory affairs, with operations strictly guided by ICH, cGMP, and USFDA guidelines. A strategic leader with expertise in business development and global marketing.
Over a distinguished career, he has worked with leading global pharmaceutical companies, including Ranbaxy Labs, Sun Pharma, Aurobindo Pharma, Jubilant Pharma, and Macleods Pharma. An accomplished researcher and industry innovator, he also holds 10 patents and has authored 2 scientific publications.
Licensed financial professional in USA. Proven track record globally with 5 years of experience in financial and marketing operations. Expert in building and developing entrepreneurs in the financial services industry.
Implementing systems in startup companies. Knowledge in ensuring appropriate organisational policies and participating in development of mission and strategic plan for companies and organisations.
Development and manufacturing of key starting materials and API intermediates — the essential building blocks in multi-step API synthesis, produced under ICH Q7 GMP guidance.
Bespoke, high-purity compounds tailored to client specifications from milligram to ton scale — accelerating drug discovery with route optimisation and scalable solutions under GMP.
Comprehensive process improvement and technology transfer services — bridging R&D to commercial manufacturing with maximum efficiency and full regulatory compliance.
Expert synthesis, isolation, and purification of API impurities, degradation products, process impurities, genotoxic impurities (GTIs), nitrosamines, and metabolites with ICH-grade characterisation.
Rigorous quality control using H-NMR, HPLC, LC-MS, and KF data — every compound supplied with a comprehensive Certificate of Analysis (CoA).
All products meet ICH guidelines, supporting stability studies, method validation, and impurity profiling for regulatory submissions worldwide.
To provide cost-effective and time-bound high-quality API intermediates, specialty chemicals and impurity synthesis services to the pharmaceutical industry. Our goal is to know the exact needs of our customers and provide our products and services to their complete satisfaction.
To become a globally trusted, sustainable partner in healthcare by delivering high-quality, innovative, and cost-effective solutions — contributing to improved quality of life and society's greater good through sustained efforts in developing and manufacturing safe, innovative and affordable pharmaceuticals.
Our quality system isn't a framed certificate on the wall — it's a set of operating principles that every chemist, every analyst, every shipment is held to.